A New Approach to Vaccine Development
A Discussion of the Institute of Medicine Committee Recommendations

The current system of supplying vaccines appears to be in a state of crisis. While immunization rates among children are high, there have been periodic shortages of vaccines. In addition, there are few incentives to develop new vaccines, and a declining number of manufacturers. That has raised concerns that we would not adequately be protected against potential bioterrorist attacks or future outbreaks of serious diseases. To address this crisis a recent report by the Institute of Medicine (IOM) calls for major changes in the current system of financing vaccine purchases. The IOM recommends a government mandate that all public and private health insurance programs cover vaccines, a voucher to uninsured individuals to assure their coverage, and government subsidies for vaccines based on an estimate of their value to society.

An eleven-person panel chaired by Duke University economist Frank Sloan devised the IOM report and its recommendations. Professor Sloan and panel members Sara Rosenbaum and Mark Pauly will present the report’s findings. The report’s conclusions will be assessed by three experts in the pharmaceutical and health insurance markets: AEI economist John Calfee; Christine Grant, vice president of AventisPasteur, a major vaccine producer; and Carmella Bocchino, vice president of the association of health insurers and health plans. The IOM report: Financing Vaccines in the 21st Century: Assuring Access and Availability is available online.

Also Visit
AEIdeas Blog The American Magazine
About the Author

 

John E.
Calfee
  • Economist John E. Calfee (1941-2011) studied the pharmaceutical industry and the Food and Drug Administration (FDA), along with the economics of tobacco, tort liability, and patents. He previously worked at the Federal Trade Commission's Bureau of Economics. He had also taught marketing and consumer behavior at the business schools of the University of Maryland at College Park and Boston University. While Mr. Calfee's writings are mostly on pharmaceutical markets and FDA regulation, his academic articles and opinion pieces covered a variety of topics, from patent law and tort liability to advertising and consumer information. His books include Prices, Markets, and the Pharmaceutical Revolution (AEI Press, 2000) and Biotechnology and the Patent System (AEI Press, 2007). Mr. Calfee wrote regularly for AEI's Health Policy Outlook series. He testified before Congress and federal agencies on various topics, including alcohol advertising; biodefense vaccine research; international drug prices; and FDA oversight of drug safety.

 

Robert B.
Helms

 

Mark V.
Pauly

What's new on AEI

We still don't know how many people Obamacare enrolled
image The war on invisible poverty
image Cutting fat from the budget
image Speaker of the House John Boehner on resetting America’s economic foundation
AEI on Facebook
Events Calendar
  • 22
    MON
  • 23
    TUE
  • 24
    WED
  • 25
    THU
  • 26
    FRI
Monday, September 22, 2014 | 2:30 p.m. – 4:00 p.m.
Policy implications of the new US labor market normal

We welcome you to join us as a panel of economists discuss US wage and price prospects in the coming months and the implications for the Federal Reserve’s current unorthodox monetary policy.

No events scheduled today.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.